Skip to main content

Table 1 Patient Characteristics

From: Antifungal stewardship in a tertiary care paediatric hospital: the PROAFUNGI study

  Total
Clinical characteristics, n 55
• Age, y, median (IQR) 8.7 (2.4–13.8)
• Male sex, n (%) 29 (53)
Underlying disease
• Cancer, n (%) 25 (45.5)
HSCT, n (%) 15/25 (60)
• Critical paediatric patients, n (%) 14 (25.5)
• Critical newborns, n (%) 5 (9)
• Primary immunodeficiencies, n (%) 5 (9)
• Solid organ transplant, n (%) 3 (5.5)
• Other, n (%) 3 (5.5)
Clinical situationa
• Risk of IFI, n (%) 27 (49)
• Suspicion of IFI, n (%) 6 (11)
• Possible IFI, n (%) 14 (25)
• Probable IFI, n (%) 2 (4)
• Proven IFI, n (%) 6 (11)
Microorganisms
Candida spp. 2/6
• Moulds 4/6
  1. Abbreviations: IFI invasive fungal infection
  2. aIFI category was defined according to the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) definitions
\